Project Details
| Status | Active |
|---|---|
| Effective start/end date | 9/19/23 → 9/2/30 |
Funding
- NRG ONCOLOGY FOUNDATION, INC.
- NIH NATIONAL CANCER INSTITUTE
A Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab or trastuzumab/pertuzumab in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma
- Erickson, Britt K (PI)
Project: Research project